Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our strategy employs molecular simulations to explore an extensive range of proteins, capturing their dynamics both individually and within complexes with other proteins. Through ensemble virtual screening, we address proteins' conformational mobility, uncovering key binding sites at both functional regions and remote allosteric locations. This comprehensive investigation ensures a thorough assessment of all potential mechanisms of action, with the goal of discovering innovative therapeutic targets and lead molecules across across diverse biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
Q9Y5X2
UPID:
SNX8_HUMAN
Alternative names:
-
Alternative UPACC:
Q9Y5X2; A4D207; Q96I67
Background:
Sorting nexin-8 plays a crucial role in intracellular trafficking, facilitating protein transport from early endosomes to the trans-Golgi network. This process is vital for the proper functioning of cellular components and the maintenance of cellular integrity.
Therapeutic significance:
Understanding the role of Sorting nexin-8 could open doors to potential therapeutic strategies. Its involvement in intracellular protein transport suggests its potential as a target in diseases where this process is disrupted.